Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Mar;75(4):312-5.
doi: 10.1055/s-0028-1088367. Epub 2008 Nov 25.

Inhibition of human dendritic cell activation by hydroethanolic but not lipophilic extracts of turmeric (Curcuma longa)

Affiliations

Inhibition of human dendritic cell activation by hydroethanolic but not lipophilic extracts of turmeric (Curcuma longa)

Joseph Krasovsky et al. Planta Med. 2009 Mar.

Abstract

Turmeric has been extensively utilized in Indian and Chinese medicine for its immune-modulatory properties. Dendritic cells (DCs) are antigen-presenting cells specialized to initiate and regulate immunity. The ability of DCs to initiate immunity is linked to their activation status. The effects of turmeric on human DCs have not been studied. Here we show that hydroethanolic (HEE) but not lipophilic "supercritical" extraction (SCE) of turmeric inhibits the activation of human DCs in response to inflammatory cytokines. Treatment of DCs with HEE also inhibits the ability of DCs to stimulate the mixed lymphocyte reaction (MLR). Importantly, the lipophilic fraction does not synergize with the hydroethanolic fraction for the ability of inhibiting DC maturation. Rather, culturing of DCs with the combination of HEE and SCE leads to partial abrogation of the effects of HEE on the MLR initiated by DCs. These data provide a mechanism for the anti-inflammatory properties of turmeric. However, they suggest that these extracts are not synergistic and may contain components with mutually antagonistic effects on human DCs. Harnessing the immune effects of turmeric may benefit from specifically targeting the active fractions.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Hydroethanolic extracts (HEE) of turmeric inhibit maturation of human monocyte-derived DCs in response to inflammatory cytokines. (A) Monocyte-derived DCs were cultured with 10 μg/mL of turmeric extracts or controls for 2 h, prior to the addition of the inflammatory cytokine cocktail. After overnight culturing, the expression of CD80, CD86, and CD83 was monitored by flow cytometry. Data are representative of 4 separate experiments. Numbers represent mean fluorescent intensity. (B) Summary of experiments. *P < 0.05. (C) DCs were treated with hydroethanolic extracts or with curcumin (CCM) at 10μM, and the expression of CD80, CD86, and CD83 was monitored after the addition of inflammatory cytokines, as in Fig. 1A. *P < 0.05 compared with vehicle controls.
Fig. 2
Fig. 2
Lack of synergy between HEE and SCE of turmeric. (A) DCs were cultured with 10 μg/mL of each extract separately or together, prior to activation with a cocktail of inflammatory cytokines (CC) as described in the methods. After overnight culturing, the expression of markers associated with DC maturation was analyzed by flow cytometry. Data are representative of 3 similar experiments. (B) Cytokine-matured DCs obtained from the cultures as in Fig. 2A were used to stimulate allogeneic lymphocytes. The proliferation of responding cells was analyzed based on tritium incorporation (CPM: counts per minute). Data are representative of two similar experiments.

References

    1. Jagetia GC, Aggarwal BB. “Spicing up” of the immune system by curcumin. J Clin Immunol. 2007;27:19–35. - PubMed
    1. Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: the Indian solid gold. Adv Exp Med Biol. 2007;595:1–75. - PubMed
    1. Sandur SK, Pandey MK, Sung B, Ahn KS, Murakami A, Sethi G, et al. Curcumin, demethoxycurcumin, bisdemothoxycurcumin, tetrahydrocurcumin, and turmerones differentially regulate anti-inflammatory and antiproliferative responses through a ROS-independent mechanism. Carcinogenesis. 2007;28:1765–73. - PubMed
    1. Kurup VP, Barrios CS, Raju R, Johnson BD, Levy MB, Fink JN. Immune response modulation by curcumin in a latex allergy model. Clin Mol Allergy. 2007;5:1. - PMC - PubMed
    1. Ranjan D, Chen C, Johnston TD, Jeon H, Nagabhushan M. Curcumin inhibits mitogen stimulated lymphocyte proliferation, NFkappaB activation, and IL-2 signaling. J Surg Res. 2004;121:171–7. - PubMed

Publication types